Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma

Melanoma Research

Volumn 26, Issue 3, 2016, Pages 319-320

  Mehta, Anurag ^a   Gupta, Arjun ^a   Hannallah, Franck ^a   Koshy, Thomas ^b   Reimold, Sharon ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; IPILIMUMAB; METHYLPREDNISOLONE; NIVOLUMAB; PREDNISONE; TRAMETINIB; TROPONIN T; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

AGED; ARM PAIN; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CASE REPORT; DIARRHEA; DRUG DOSE REDUCTION; DRUG INFUSION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FEVER; HUMAN; LETTER; LUNG LESION; MALAISE; METASTATIC MELANOMA; MULTIPLE PULMONARY NODULES; MYOCARDITIS; PRIORITY JOURNAL; THORAX PAIN; CHEMICALLY INDUCED; MELANOMA;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; IPILIMUMAB; MELANOMA; MYOCARDITIS;

EID: 84966589355     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0000000000000251     Document Type: Letter

References (5)

1. U.S. Food and Drug Administration. Nivolumab in combination with ipilimumab; 2015. Available at: http://www.fda.gov/Drugs/ InformationOnDrugs/ApprovedDrugs/ucm465274.htm. [Accessed 17 November 2015].
2. U.S. National Cancer Institute. NCI Common Terminology Criteria for Adverse Events (CTCAE); 2009. Available at: http://evs.nci.nih.gov/ftp1/CTCAE/ About.html. [Accessed 23 November 2015].
3. Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 2015; 373:23-34.
4. Geisler BP, Raad RA, Esaian D, Sharon E, Schwartz DR. Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome. J Immunother Cancer 2015; 3:4.
5. Läubli H, Balmelli C, Bossard M, Pfister O, Glatz K, Zippelius A. Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma. J Immunother Cancer 2015; 3:11.